These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33900501)

  • 21. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?
    Senders ZJ; Bartlett EK; Mouw TJ; McMasters KM; Egger ME
    Ann Surg Oncol; 2023 Jun; 30(6):3648-3654. PubMed ID: 36934378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma.
    Sharma AS; Flynn JR; Panageas KS; Shahrokni A; Tin AL; Bello DM; Ariyan CE; Brady MS; Coit DG; Bartlett EK
    Ann Surg Oncol; 2021 Dec; 28(13):9031-9038. PubMed ID: 34085141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
    Dixon AJ; Kyrgidis A; Steinman HK; Dixon JB; Sladden M; Garbe C; Lallas A; Zachary CB; Leiter-Stöppke U; Smith H; Nirenberg A; Zouboulis CC; Longo C; Argenziano G; Apalla Z; Popescu C; Tzellos T; Anderson S; Nanz L; Cleaver L; Thomas JM
    J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):741-751. PubMed ID: 38168748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
    Narang J; Hue JJ; Bingmer K; Hardacre JM; Winter JM; Ocuin LM; Ammori JB; Mangla A; Bordeaux J; Rothermel LD
    J Surg Oncol; 2021 Sep; 124(4):669-678. PubMed ID: 34109633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?
    Puza CJ; Josyula S; Terando AM; Howard JH; Agnese DM; Mosca PJ; Lee WT; Beasley GM
    J Surg Oncol; 2018 Jun; 117(7):1584-1588. PubMed ID: 29513892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
    Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
    Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
    Monroe MM; Pattisapu P; Myers JN; Kupferman ME
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Patient Age and Lymph Node Positivity in Thin Melanoma.
    Sinnamon AJ; Neuwirth MG; Yalamanchi P; Gimotty P; Elder DE; Xu X; Kelz RR; Roses RE; Chu EY; Ming ME; Fraker DL; Karakousis GC
    JAMA Dermatol; 2017 Sep; 153(9):866-873. PubMed ID: 28724122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The limited value of sentinel lymph node biopsy in lentigo maligna melanoma: A nomogram based on the results of 29 years of the nationwide dutch pathology registry (PALGA).
    Elshot YS; Bruijn TVM; Ouwerkerk W; Jaspars LH; van de Wiel BA; Zupan-Kajcovski B; de Rie MA; Bekkenk MW; Balm AJM; Klop WMC
    Eur J Surg Oncol; 2023 Nov; 49(11):107053. PubMed ID: 37778193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands.
    Verstijnen J; Damude S; Hoekstra HJ; Kruijff S; Ten Tije AJ; Louwman WJ; Bastiaannet E; Stuiver MM
    Surg Oncol; 2017 Dec; 26(4):431-437. PubMed ID: 29113662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
    MacArthur KM; Baumann BC; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Krausz A; Newman JG; Rajasekaran K; Cannady SB; Brody RM; Karakousis GC; Miura JT; Cohen JV; Amaravadi RK; Mitchell TC; Schuchter LM; Miller CJ
    Cancer; 2021 Oct; 127(19):3591-3598. PubMed ID: 34292585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compounding Benefits of Sentinel Lymph Node Biopsy for Perineal Melanoma: A Population-Based Retrospective Cohort Analysis.
    Patel RA; Patel PD; Ashack K; Borrelli MR; Trickey A; Wan DC
    Ann Plast Surg; 2020 May; 84(5S Suppl 4):S257-S263. PubMed ID: 32282396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural history of thin melanoma and the utility of sentinel lymph node biopsy.
    Durham AB; Schwartz JL; Lowe L; Zhao L; Johnson AG; Harms KL; Bichakjian CK; Orsini AP; McLean SA; Bradford CR; Cohen MS; Johnson TM; Sabel MS; Wong SL
    J Surg Oncol; 2017 Dec; 116(8):1185-1192. PubMed ID: 28715140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications.
    Grotz TE; Puig CA; Perkins S; Ballman K; Hieken TJ
    Eur J Surg Oncol; 2015 Jan; 41(1):157-64. PubMed ID: 25468751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy.
    Borgognoni L; Crocetti E; Sestini S; Brandani P; Giannotti V; Gerlini G
    Melanoma Res; 2022 Dec; 32(6):469-476. PubMed ID: 36317389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
    Blankenstein SA; Bonenkamp JJ; Aarts MJB; van den Berkmortel FWPJ; Blank CU; Blokx WAM; Boers-Sonderen MJ; van den Eertwegh AJM; Franken MG; de Groot JWB; Haanen JBAG; Hospers GAP; Kapiteijn EW; van Not OJ; Piersma D; van Rijn RS; Suijkerbuijk KPM; van der Veldt AAM; Vreugdenhil G; Westgeest HM; Wouters MWJM; van Akkooi ACJ
    Ann Surg Oncol; 2023 Jan; 30(1):573-586. PubMed ID: 36203067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of sentinel node positivity in primary cutaneous melanoma: an 8-year single institution experience.
    Joyce KM; McInerney NM; Piggott RP; Martin F; Jones DM; Hussey AJ; Kerin MJ; Kelly JL; Regan PJ
    Ir J Med Sci; 2017 Nov; 186(4):847-853. PubMed ID: 28132159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.